Polyethylene Glycol Loxenatide (PEX-168) Reduces Body Weight and Blood Glucose in Simple Obese Mice

BACKGROUND: At present, there is a lack of drug treatment for obese patients, so it is needed to find a drug that is effective and has few side effects to treat obesity. PEX-168 is a novel long-acting glucagon-like peptide-1 receptor agonist for T2DM. It improves blood glucose with fewer side effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuting, Guo, Zeyuan, Wang, Junlu, Wang, Yong, Wang, Daorong, Li, Ying, Zhu, Lihua, Sun, Xiaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550851/
https://www.ncbi.nlm.nih.gov/pubmed/34721575
http://dx.doi.org/10.1155/2021/9951463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550851/
https://www.ncbi.nlm.nih.gov/pubmed/34721575
http://dx.doi.org/10.1155/2021/9951463

Ejemplares similares